{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:20:00Z","timestamp":1792264800628,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002402","name":"Sun Yat-sen University","doi-asserted-by":"publisher","award":["YXQH202419"],"award-info":[{"award-number":["YXQH202419"]}],"id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010883","name":"Traditional Chinese Medicine Bureau of Guangdong Province","doi-asserted-by":"publisher","award":["20241054"],"award-info":[{"award-number":["20241054"]}],"id":[{"id":"10.13039\/501100010883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010883","name":"Traditional Chinese Medicine Bureau of Guangdong Province","doi-asserted-by":"publisher","award":["20221075"],"award-info":[{"award-number":["20221075"]}],"id":[{"id":"10.13039\/501100010883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013183","name":"Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013183","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002369","name":"Chongqing University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002369","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515012014"],"award-info":[{"award-number":["2023A1515012014"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515010304"],"award-info":[{"award-number":["2023A1515010304"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515010916"],"award-info":[{"award-number":["2023A1515010916"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515011238"],"award-info":[{"award-number":["2024A1515011238"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203086"],"award-info":[{"award-number":["82203086"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173232"],"award-info":[{"award-number":["82173232"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["202201010807"],"award-info":[{"award-number":["202201010807"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.biomaterials.2025.123787","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T22:24:19Z","timestamp":1760394259000},"page":"123787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["A TNBC-targeting nano-radiosensitizer reverses radioresistance by synergizing GSH scavenging with dual inhibition of Trop2 and lncRNA MNX1-AS1"],"prefix":"10.1016","volume":"327","author":[{"given":"Zhiwei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4490-6042","authenticated-orcid":false,"given":"Bianfei","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7971-4186","authenticated-orcid":false,"given":"Hongwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingjian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8914-4446","authenticated-orcid":false,"given":"Zhuofei","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2025.123787_bib1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.canlet.2020.10.016","article-title":"Triple-negative breast cancer therapeutic resistance: where is the Achilles' heel?","volume":"497","author":"Bai","year":"2021","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123787_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13014-020-01501-x","article-title":"Recent advances in radiotherapy of breast cancer","volume":"15","author":"Haussmann","year":"2020","journal-title":"Radiat. Oncol."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123787_bib3","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/S1470-2045(14)71104-0","article-title":"Radiation therapy in the locoregional treatment of triple-negative breast cancer","volume":"16","author":"Moran","year":"2015","journal-title":"Lancet Oncol."},{"issue":"12","key":"10.1016\/j.biomaterials.2025.123787_bib4","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1001\/jamaoncol.2022.5074","article-title":"Concurrent olaparib and radiotherapy in patients with triple-negative breast cancer: the phase 1 olaparib and radiation therapy for triple-negative breast cancer trial","volume":"8","author":"Loap","year":"2022","journal-title":"JAMA Oncol."},{"issue":"10286","key":"10.1016\/j.biomaterials.2025.123787_bib5","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","article-title":"Breast cancer","volume":"397","author":"Loibl","year":"2021","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123787_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202301131","article-title":"Stimuli-responsive nanoradiosensitizers for enhanced cancer radiotherapy","volume":"8","author":"Xiao","year":"2024","journal-title":"Small Methods"},{"key":"10.1016\/j.biomaterials.2025.123787_bib7","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jconrel.2024.05.039","article-title":"Intracellular Criegee's mechanism-based synergistic ozone therapy mediated by oleogels for cancer treatment","volume":"370","author":"Lu","year":"2024","journal-title":"J. Contr. Release"},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123787_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201802244","article-title":"Emerging strategies of nanomaterial-mediated tumor radiosensitization","volume":"31","author":"Xie","year":"2019","journal-title":"Adv Mater"},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123787_bib9","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1083\/jcb.201804161","article-title":"Glutathione metabolism in cancer progression and treatment resistance","volume":"217","author":"Bansal","year":"2018","journal-title":"J. Cell Biol."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123787_bib10","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1016\/j.apsb.2023.03.013","article-title":"Emerging roles of Aurora-A kinase in cancer therapy resistance","volume":"13","author":"Zheng","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123787_bib11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41392-020-0150-x","article-title":"DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123787_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/jcb.30361","article-title":"Mechanisms of radioresistance and the underlying signaling pathways in colorectal cancer cells","volume":"124","author":"Tessmann","year":"2023","journal-title":"J. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123787_bib13","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1002\/hep.32615","article-title":"Methyltransferase 1 is required for nonhomologous end-joining repair and renders hepatocellular carcinoma resistant to radiotherapy","volume":"77","author":"Liao","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123787_bib14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12943-023-01839-2","article-title":"Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma","volume":"22","author":"An","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biomaterials.2025.123787_bib15","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.canlet.2021.10.001","article-title":"SERPINE2\/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer","volume":"524","author":"Zhang","year":"2022","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123787_bib16","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1186\/s12967-023-04394-y","article-title":"JMJD6-BRD4 complex stimulates lncRNA HOTAIR transcription by binding to the promoter region of HOTAIR and induces radioresistance in liver cancer stem cells","volume":"21","author":"Pei","year":"2023","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123787_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s10020-020-00255-2","article-title":"Role of long non-coding RNA H19 in therapy resistance of digestive system cancers","volume":"27","author":"Wang","year":"2021","journal-title":"Mol Med"},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123787_bib18","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ijrobp.2017.11.043","article-title":"Blocking interleukin (IL)4- and IL13-Mediated phosphorylation of STAT6 (Tyr641) decreases M2 polarization of macrophages and protects against macrophage-mediated radioresistance of inflammatory breast cancer","volume":"100","author":"Rahal","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.biomaterials.2025.123787_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115242","article-title":"Molecular landscape of LncRNAs in bladder cancer: from drug resistance to novel LncRNA-based therapeutic strategies","volume":"165","author":"Mehmandar-Oskuie","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biomaterials.2025.123787_bib20","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.omtn.2023.07.009","article-title":"Role of long non-coding RNAs in cancer: from subcellular localization to nanoparticle-mediated targeted regulation","volume":"33","author":"Wei","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.biomaterials.2025.123787_bib21","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.3389\/fonc.2020.01108","article-title":"Long non-coding RNA MNX1-AS1 promotes progression of triple negative breast cancer by enhancing phosphorylation of Stat3","volume":"10","author":"Li","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biomaterials.2025.123787_bib22","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3389\/fonc.2020.01120","article-title":"STAT3 contributes to radioresistance in cancer","volume":"10","author":"Wang","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biomaterials.2025.123787_bib23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jare.2023.09.011","article-title":"CDK2-activated TRIM32 phosphorylation and nuclear translocation promotes radioresistance in triple-negative breast cancer","volume":"61","author":"Tang","year":"2024","journal-title":"J. Adv. Res."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123787_bib24","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/09553002.2020.1705423","article-title":"Radiation induces an inflammatory response that results in STAT3-dependent changes in cellular plasticity and radioresistance of breast cancer stem-like cells","volume":"96","author":"Arnold","year":"2020","journal-title":"Int. J. Radiat. Biol."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123787_bib25","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/s41388-022-02204-1","article-title":"TRIM32 promotes radioresistance by disrupting TC45-STAT3 interaction in triple-negative breast cancer","volume":"41","author":"Ma","year":"2022","journal-title":"Oncogene"},{"issue":"39","key":"10.1016\/j.biomaterials.2025.123787_bib26","doi-asserted-by":"crossref","first-page":"5292","DOI":"10.1038\/s41388-018-0340-y","article-title":"Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide","volume":"37","author":"Lu","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.biomaterials.2025.123787_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.addr.2019.05.004","article-title":"Strategies, design, and chemistry in siRNA delivery systems","volume":"144","author":"Dong","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2025.123787_bib28","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.2147\/IJN.S322901","article-title":"TME-responsive multistage nanoplatform for siRNA delivery and effective cancer therapy","volume":"16","author":"Cao","year":"2021","journal-title":"Int. J. Nanomed."},{"issue":"36","key":"10.1016\/j.biomaterials.2025.123787_bib29","article-title":"Stimuli-responsive nanotechnology for RNA delivery","volume":"10","author":"Zhou","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123787_bib30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41392-020-0207-x","article-title":"Therapeutic siRNA: state of the art","volume":"5","author":"Hu","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123787_bib31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41576-021-00439-4","article-title":"Drug delivery systems for RNA therapeutics","volume":"23","author":"Paunovska","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.biomaterials.2025.123787_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114113","article-title":"RNAi-based therapeutics and tumor targeted delivery in cancer","volume":"182","author":"Kara","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"17","key":"10.1016\/j.biomaterials.2025.123787_bib33","doi-asserted-by":"crossref","first-page":"7921","DOI":"10.7150\/thno.49577","article-title":"The EPR effect and beyond: strategies to improve tumor targeting and cancer nanomedicine treatment efficacy","volume":"10","author":"Shi","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.biomaterials.2025.123787_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114614","article-title":"The tumor EPR effect for cancer drug delivery: current status, limitations, and alternatives","volume":"191","author":"Sun","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2025.123787_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108296","article-title":"Advances in Trop2-targeted therapy: novel agents and opportunities beyond breast cancer","volume":"239","author":"Liu","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"24","key":"10.1016\/j.biomaterials.2025.123787_bib36","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.21037\/atm-22-5976","article-title":"A literature review of the promising future of TROP2: a potential drug therapy target","volume":"10","author":"Wen","year":"2022","journal-title":"Ann. Transl. Med."},{"issue":"30","key":"10.1016\/j.biomaterials.2025.123787_bib37","doi-asserted-by":"crossref","first-page":"11513","DOI":"10.1074\/jbc.RA119.008084","article-title":"Trophoblast cell surface antigen 2 (Trop-2) phosphorylation by protein kinase C \u03b1\/\u03b4 (PKC\u03b1\/\u03b4) enhances cell motility","volume":"294","author":"Mori","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123787_bib38","first-page":"753","article-title":"TROP2 promotes the proliferation and metastasis of glioblastoma cells by activating the JAK2\/STAT3 signaling pathway","volume":"41","author":"Hou","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biomaterials.2025.123787_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2023.109417","article-title":"Selenium modulates AR\/IGF-1R\/EGFR and TROP2 signaling pathways and improves anticancer efficacy in murine mammary carcinoma 4T1","volume":"120","author":"Guo","year":"2023","journal-title":"J. Nutr. Biochem."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123787_bib40","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.7150\/thno.98178","article-title":"Trop2-targeted therapies in solid tumors: advances and future directions","volume":"14","author":"Liu","year":"2024","journal-title":"Theranostics"},{"issue":"32","key":"10.1016\/j.biomaterials.2025.123787_bib41","doi-asserted-by":"crossref","first-page":"9218","DOI":"10.1002\/anie.201503863","article-title":"Hydrophobic cysteine poly(disulfide)-based redox-hypersensitive nanoparticle platform for cancer theranostics","volume":"54","author":"Wu","year":"2015","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"18","key":"10.1016\/j.biomaterials.2025.123787_bib42","article-title":"Nanoparticles (NPs)-Meditated LncRNA AFAP1-AS1 silencing to block Wnt\/\u03b2-Catenin signaling pathway for synergistic reversal of radioresistance and effective cancer radiotherapy","volume":"7","author":"Bi","year":"2020","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"46","key":"10.1016\/j.biomaterials.2025.123787_bib43","doi-asserted-by":"crossref","first-page":"18638","DOI":"10.1073\/pnas.1303958110","article-title":"Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug","volume":"110","author":"Xu","year":"2013","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.biomaterials.2025.123787_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121264","article-title":"Reduction-responsive RNAi nanoplatform to reprogram tumor lipid metabolism and repolarize macrophage for combination pancreatic cancer therapy","volume":"280","author":"Cao","year":"2022","journal-title":"Biomaterials"},{"issue":"24","key":"10.1016\/j.biomaterials.2025.123787_bib45","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1038\/s41388-021-01839-w","article-title":"Oncogenic long intervening noncoding RNA Linc 00284 promotes c-Met expression by sponging miR-27a in colorectal cancer","volume":"40","author":"You","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.biomaterials.2025.123787_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112801","article-title":"LncRNA MNX1-AS1: a novel oncogenic propellant in cancers","volume":"149","author":"Li","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biomaterials.2025.123787_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108118","article-title":"The role of the STAT3 signaling transduction pathways in radioresistance","volume":"234","author":"Shih","year":"2022","journal-title":"Pharmacol. Ther."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225007069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225007069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:02:40Z","timestamp":1780477360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961225007069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":47,"alternative-id":["S0142961225007069"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123787","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A TNBC-targeting nano-radiosensitizer reverses radioresistance by synergizing GSH scavenging with dual inhibition of Trop2 and lncRNA MNX1-AS1","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123787"}}